USGI Medical Receives FDA Approval to Expand US Pilot Study Evaluating Incisionless Weight Loss Procedure – POSE 2.0

NEXT STORY
Clinical Experts Discuss Fluid Management Strategies in Critically Ill COVID-19 Patients during CHF Solutions Webinar
PREV STORY
PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer

author_avatar
NASDAQ Market News

Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis

author_avatar
NASDAQ Market News